A detailed history of Carolina Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Carolina Wealth Advisors, LLC holds 30 shares of NVS stock, worth $2,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Holding current value
$2,972
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$106.13 - $120.89 $3,183 - $3,626
30 New
30 $3,000
Q2 2022

Jul 19, 2022

BUY
$80.52 - $93.75 $0 - $0
0 New
0 $0
Q3 2021

Oct 22, 2021

SELL
$81.78 - $95.14 $2,780 - $3,234
-34 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $7,160 - $7,908
-84 Reduced 71.19%
34 $3,000
Q1 2021

Apr 09, 2021

BUY
$83.5 - $98.47 $7,014 - $8,271
84 Added 247.06%
118 $10,000
Q4 2020

Jan 29, 2021

SELL
$78.07 - $94.43 $3,825 - $4,627
-49 Reduced 59.04%
34 $3,000
Q3 2020

Oct 19, 2020

BUY
$82.14 - $91.0 $6,817 - $7,553
83 New
83 $7,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carolina Wealth Advisors, LLC Portfolio

Follow Carolina Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolina Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolina Wealth Advisors, LLC with notifications on news.